Financial Performance - The company's operating revenue for Q1 2023 was ¥105,164,387.97, representing a year-on-year increase of 4.35%[3] - The net profit attributable to shareholders decreased by 7.33% to ¥14,010,691.86 compared to the same period last year[3] - The basic and diluted earnings per share were both ¥0.17, reflecting a decrease of 5.56% compared to the previous year[3] - In Q1 2023, the company's net profit was CNY 14,077,664.52, a decrease of 5.95% compared to CNY 14,971,258.43 in Q1 2022[15] - Operating profit for Q1 2023 was CNY 15,192,408.18, down 6.77% from CNY 16,292,842.13 in Q1 2022[15] - The company reported a total comprehensive income of CNY 13,985,390.56, compared to CNY 14,943,977.53 in Q1 2022, reflecting a decline of 6.41%[16] Research and Development - Research and development expenses totaled ¥13,427,698.79, an increase of 26.43% year-on-year, accounting for 12.77% of operating revenue, up by 2.23 percentage points[3] - Research and development expenses increased to CNY 13,427,698.79, up 26.00% from CNY 10,620,937.62 in the same period last year[15] Cash Flow and Liquidity - The net cash flow from operating activities increased significantly by 62.39% to ¥18,408,899.86, primarily due to cash received from sales of goods and services[4] - The net cash flow from operating activities was CNY 18,408,899.86, up 62.00% from CNY 11,336,299.37 in the previous year[18] - Cash and cash equivalents as of March 31, 2023, were RMB 331,569,007.32, down from RMB 409,550,241.98 at the end of 2022, a decrease of approximately 19%[10] - The cash and cash equivalents at the end of Q1 2023 were CNY 306,420,034.72, down from CNY 377,674,087.33 at the end of Q1 2022[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥855,036,693.60, down 4.36% from the end of the previous year[4] - Total assets as of March 31, 2023, were RMB 855,036,693.60, down from RMB 894,019,246.65 at the end of 2022, a decline of about 4.4%[12] - Total liabilities decreased to RMB 114,178,123.46 from RMB 167,146,067.07, a reduction of approximately 31.6%[12] - The equity attributable to shareholders increased to RMB 733,021,054.64 from RMB 719,102,636.74, reflecting a growth of about 1.9%[12] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 5,148[5] - The largest shareholder, Shanghai Buke Information Consulting Co., Ltd., holds 44.02% of the shares, totaling 36,979,753 shares[6] Sales and Market Strategy - The company has strengthened its sales mechanism targeting key clients, resulting in an 11.10% increase in sales expenses compared to the previous year[4] - Total revenue from sales of goods and services reached CNY 113,921,642.91, an increase from CNY 103,082,599.30 in Q1 2022[17] - The company is focusing on expanding its market presence and enhancing product development, although detailed strategies were not provided in the report[14]
步科股份(688160) - 2023 Q1 - 季度财报